4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-052036
Chief Scientific Officer sold 33,300 shares at an average $47.61 ($1,585,430)
- Chief Scientific Officer acquired 33,300 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ROBINS HARLAN S · Chief Scientific Officer
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-09-22 | Exercise or conversion : show line 1 in the form | +11,100 | $6.32 | $70,152 | 11,779 | D |
| 2020-09-22 | Sale : show line 2 in the form | −7,000 | $47.34 | $331,380 | 4,779 | D |
| 2020-09-22 | Sale : show line 3 in the form | −4,100 | $47.95 | $196,595 | 679 | D |
| 2020-09-23 | Exercise or conversion : show line 4 in the form | +11,100 | $6.32 | $70,152 | 11,779 | D |
| 2020-09-23 | Sale : show line 5 in the form | −11,100 | $48.16 | $534,576 | 679 | D |
| 2020-09-24 | Exercise or conversion : show line 6 in the form | +11,100 | $6.32 | $70,152 | 11,779 | D |
| 2020-09-24 | Sale : show line 7 in the form | −3,640 | $46.00 | $167,440 | 8,139 | D |
| 2020-09-24 | Sale : show line 8 in the form | −3,560 | $47.28 | $168,317 | 4,579 | D |
| 2020-09-24 | Sale : show line 9 in the form | −3,900 | $47.98 | $187,122 | 679 | D |
| Open-market sales · 33,300 sh · avg $47.61 · $1,585,430 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-09-22 | Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) | −11,100 | 322,500 | D |
| 2020-09-23 | Exercise or conversion : show line 11 in the form Stock Option (Right to Buy) | −11,100 | 311,400 | D |
| 2020-09-24 | Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) | −11,100 | 300,300 | D |
Loading xslF345X03/doc4.xml…